7 Ways to Stop Post-Nasal Drip, According to Doctors
Another natural method that may help you find relief from environmental factors behind your post-nasal drip is by inhaling ...
The Hollywood Reporter17 天
These Fashion, Beauty and Home Brands Are Donating Proceeds to L.A. Wildfire Relief
A running list of brands supporting fire relief efforts in Los Angeles. By Erin Lassner, Laurie Brookins If you purchase an independently reviewed product or service through a link on our website ...
healthday17 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
U.S. News & World Report17 天
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
The Hill17 天
Nose spray to treat depression? FDA approves first-of-its-kind medicine
The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson & Johnson. The main ingredient for the ...
Newsweek17 天
FDA Approves Nasal Spray for Depression
This new treatment could help bring relief for millions of Americans struggling with depression. The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for ...
Gizmodo18 天
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...
Fast Company18 天
Johnson & Johnson ketamine-derived nasal spray gets FDA approval for depression, but JNJ ...
On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...
Popular Science18 天
FDA approves first-of-its-kind nasal spray for severe depression
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
UPI18 天
FDA approves Spravato, first monotherapy nasal spray to treat depression
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
New York Magazine18 天
These Brands Are Donating Proceeds to Los Angeles Wildfire-Relief Funds
Brands are also offering free products to people or donating a percentage of their sales directly to wildfire relief. Below, you’ll find a list of companies giving back — plus some Los Angeles ...
NBC New York18 天
FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults ... Martin said that demonstrates "not only rapid symptom relief, but also a durable symptom ...